Impact of pegfilgrastim as primary prophylaxis for metastatic castration-resistant prostate cancer patients undergoing cabazitaxel treatment: an open-label study in Japan

BACKGROUND: Cabazitaxel is an efficacious treatment for patients with metastatic castration-resistant prostate cancer who have previously progressed on docetaxel, but febrile neutropenia during the first cycle is a frequent complication. Asian patients are at increased risk of febrile neutropenia. A...

Descripción completa

Detalles Bibliográficos
Autores principales: Kosaka, Takeo, Uemura, Hiroji, Sumitomo, Makoto, Harada, Kenichi, Sugimoto, Mikio, Hayashi, Narihiko, Yoshimura, Kazuhiro, Fukasawa, Satoshi, Ecstein-Fraisse, Evelyne, Sunaga, Yoshinori, Oya, Mototsugu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6939836/
https://www.ncbi.nlm.nih.gov/pubmed/31329922
http://dx.doi.org/10.1093/jjco/hyz051

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6939836/
https://www.ncbi.nlm.nih.gov/pubmed/31329922
http://dx.doi.org/10.1093/jjco/hyz051

Ejemplares similares